NO981867D0 - Polymorfe former av et middel som forÕrsaker veksthormonsekresjon - Google Patents

Polymorfe former av et middel som forÕrsaker veksthormonsekresjon

Info

Publication number
NO981867D0
NO981867D0 NO981867A NO981867A NO981867D0 NO 981867 D0 NO981867 D0 NO 981867D0 NO 981867 A NO981867 A NO 981867A NO 981867 A NO981867 A NO 981867A NO 981867 D0 NO981867 D0 NO 981867D0
Authority
NO
Norway
Prior art keywords
agent
growth hormone
polymorphic forms
hormone secretion
cause growth
Prior art date
Application number
NO981867A
Other languages
English (en)
Other versions
NO981867L (no
NO310556B1 (no
Inventor
Jerome P Draper
David C Dubost
Michael J Kaufman
James A Mccauley
Jennifer L Vandrilla
Richard J Varsolona
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603361.8A external-priority patent/GB9603361D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO981867D0 publication Critical patent/NO981867D0/no
Publication of NO981867L publication Critical patent/NO981867L/no
Publication of NO310556B1 publication Critical patent/NO310556B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
NO19981867A 1995-10-27 1998-04-24 Polymorfe former av et middel som forårsaker veksthormonsekresjon NO310556B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US590095P 1995-10-27 1995-10-27
GBGB9603361.8A GB9603361D0 (en) 1996-02-16 1996-02-16 Polymorphic forms of a growth hormone secretagogue
PCT/US1996/016955 WO1997015574A1 (en) 1995-10-27 1996-10-23 Polymorphic forms of a growth hormone secretagogue

Publications (3)

Publication Number Publication Date
NO981867D0 true NO981867D0 (no) 1998-04-24
NO981867L NO981867L (no) 1998-06-29
NO310556B1 NO310556B1 (no) 2001-07-23

Family

ID=26308741

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981867A NO310556B1 (no) 1995-10-27 1998-04-24 Polymorfe former av et middel som forårsaker veksthormonsekresjon

Country Status (22)

Country Link
EP (1) EP1019402A1 (no)
JP (1) JP3204266B2 (no)
KR (1) KR19990067098A (no)
CN (1) CN1067687C (no)
AU (1) AU707946B2 (no)
BG (1) BG102476A (no)
BR (1) BR9611229A (no)
CA (1) CA2235371A1 (no)
CO (1) CO4770956A1 (no)
CZ (1) CZ128098A3 (no)
EA (1) EA000528B1 (no)
EE (1) EE9800147A (no)
HK (1) HK1017894A1 (no)
HU (1) HUP9902208A3 (no)
IS (1) IS4721A (no)
NO (1) NO310556B1 (no)
NZ (1) NZ321370A (no)
PL (1) PL327511A1 (no)
SK (1) SK51398A3 (no)
TR (1) TR199800726T2 (no)
WO (1) WO1997015574A1 (no)
YU (1) YU56696A (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6046333A (en) * 1996-10-25 2000-04-04 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK282166B6 (sk) * 1992-12-11 2001-11-06 Merck & Co., Inc. Spiropiperidínové deriváty, spôsob ich výroby a farmaceutický prostriedok s ich obsahom

Also Published As

Publication number Publication date
CO4770956A1 (es) 1999-04-30
AU7468696A (en) 1997-05-15
KR19990067098A (ko) 1999-08-16
HUP9902208A2 (hu) 1999-10-28
EA000528B1 (ru) 1999-10-28
CN1067687C (zh) 2001-06-27
NO981867L (no) 1998-06-29
YU56696A (sh) 1999-09-27
BG102476A (en) 1999-04-30
WO1997015574A1 (en) 1997-05-01
HK1017894A1 (en) 1999-12-03
EA199800335A1 (ru) 1998-12-24
CA2235371A1 (en) 1997-05-01
JP3204266B2 (ja) 2001-09-04
BR9611229A (pt) 1999-05-25
HUP9902208A3 (en) 2001-05-28
NZ321370A (en) 1999-11-29
SK51398A3 (en) 1998-12-02
NO310556B1 (no) 2001-07-23
AU707946B2 (en) 1999-07-22
TR199800726T2 (xx) 1998-08-21
JPH10512295A (ja) 1998-11-24
IS4721A (is) 1998-04-21
PL327511A1 (en) 1998-12-21
EE9800147A (et) 1998-12-15
MX9803351A (es) 1998-09-30
CN1205703A (zh) 1999-01-20
CZ128098A3 (cs) 1998-09-16
EP1019402A1 (en) 2000-07-19

Similar Documents

Publication Publication Date Title
IS1772B (is) Aðferð við myndun útskiptra súlfoxíða
DK0869968T3 (da) Væksthormonsecerneringsfremmende stof
NO951630L (no) Fremgangsmåte for administrering av azithromycin
IS1886B (is) Stjórnuð losun stera úr sykruhúðum
NO975159L (no) Fremgangsmåte for kontroll av biologisk nedbrytning
NO996469L (no) Tartratsalt av et substituert dipeptid som et veksthormonutskillelsesmiddel
KR100196336B1 (en) Method of manufacturing thin film transistor
FI970472A (fi) Menetelmä suklaan viskositeetin vähentämiseksi
FI962370A0 (fi) Laite tissuen valmistamiseksi
FI954632A0 (fi) Korrigering av stoetbreddning hos icke-dispersiv absorptionsmaetning av gasar
NO973460L (no) Fremgangsmåte for gjenvinning av kvikksölv
FI970714A0 (fi) Menetelmä luuproteesin rappeutumisen estämiseksi
HUP9801155A3 (en) Use of vinpocetine derivatives for inhibiting production or secretion of amyloid beta protein
NO981867D0 (no) Polymorfe former av et middel som forÕrsaker veksthormonsekresjon
AU6045196A (en) Secretion leader trap cloning method
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
NO973103D0 (no) Fremgangsmåte for inhibering av veksthormoneffekter
HU9503736D0 (en) New derivatives of trans apovincaminic-acid-esters
FI972694A0 (fi) Uusi menetelmä sameridiinin valmistamiseksi
KR960038709U (ko) 웨이퍼 노광장치의 스테이지
ITAV950002U1 (it) ___regolo per il calcolo dei giorni fecondi
UA27839C2 (uk) Спосіб корекції порушеної тканинної трофіки
NO930483D0 (no) Proteaser som foraarsaker unormal degradering av amyloid-beta-protein-forloeper
KR960033017U (ko) 모니터의 라스트센터링 제어회로
TR199501045A2 (tr) Pepsin salgisini durduran peptidlerin hazirlanmasina dair yöntem.

Legal Events

Date Code Title Description
MK1K Patent expired